XML 18 R7.htm IDEA: XBRL DOCUMENT v3.21.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
6 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Cash flows from operating activities:    
Net income (loss) $ (1,718) $ 959
Adjustments to reconcile net income (loss) to net cash used in operating activities:    
Amortization of intangible assets 441 470
Depreciation 24 28
Other amortization 6 9
Change in fair value of warrant liabilities 1,859 (2,921)
Stock-based compensation 90 80
Government grant income (Note 8) (88)
Changes in operating assets and liabilities, net of business acquired    
Accounts receivable (49) 386
Prepaid expenses (112) 59
Other current assets and other assets (129) 16
Accounts payable and accrued liabilities (254) 733
Deferred revenue 126 109
Other liabilities 7 (18)
Total adjustments 1,921 (1,049)
Net cash provided by (used in) operating activities 203 (90)
Cash flows from investing activities:    
Software development capitalization costs (30)
Purchase of property and equipment (27)
Cash acquired in business combination, net of cash payments of purchase price 404
Net cash provided by investing activities 347
Cash flows from financing activities:    
Proceeds from issuance of common stock, net of issuance costs 2,462
Proceeds from stock option and warrant exercises 19
Payments of long-term debt (377)
Net cash provided by financing activities 2,104
Effect of exchange rate changes on cash and cash equivalents (18) 28
Net increase (decrease) in cash and cash equivalents 2,636 (62)
Cash and cash equivalents at beginning of period 861 296
Cash and cash equivalents at end of period 3,497 234
Supplemental disclosures of cash flow information:    
Interest 19
Income taxes 3
Non cash investing and financing activities (see Note 15):    
Consideration paid in common stock in connection with acquisition of business 99
Dividends accrued on convertible preferred stock 106
Series A Convertible Preferred Stock [Member]    
Non cash investing and financing activities (see Note 15):    
Deemed dividend on amendment of Series A convertible preferred stock $ 2,314